 | • レポートコード：20QY06-05506 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、抗がん剤のグローバル市場について種類別（細胞毒性薬（アルキル化剤、代謝拮抗薬）、標的薬（モノクローナル抗体およびチロシンキナーゼ阻害剤）、ホルモン薬）、用途別（肺癌、乳癌、白血病、大腸癌）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・抗がん剤市場の概要 ・世界の主要地域別抗がん剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗がん剤市場規模2015-2026：種類別（細胞毒性薬（アルキル化剤、代謝拮抗薬）、標的薬（モノクローナル抗体およびチロシンキナーゼ阻害剤）、ホルモン薬） ・世界の抗がん剤市場規模2015-2026：用途別（肺癌、乳癌、白血病、大腸癌） ・抗がん剤の北米市場規模2015-2020 ・抗がん剤のヨーロッパ市場規模2015-2020 ・抗がん剤の中国市場規模2015-2020 ・抗がん剤の日本市場規模2015-2020 ・抗がん剤の東南アジア市場規模2015-2020 ・抗がん剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （F. Hoffmann-La Roche Ltd、Eli Lilly and Company、CELGENE CORPORATION、Novartis AG、Pfizer Inc、Amgen Inc、Bayer AG、AstraZeneca、Takeda Pharmaceutical Company Limited、Merck & Co.） ・抗がん剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗がん剤の市場動向・機会・課題 ・調査の結論 |
Antineoplastic drugs, also known as anticancer drugs, anti-malignant drugs, refer to drugs for the treatment of malignant tumors.
Simply put, there are chemotherapy drugs and biological agents. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of tumors; the invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry, and genetic engineering have accelerated the process of drug development; research and development of anti-tumor drugs have been Enter a new era.
Market Analysis and Insights: Global Anticancer Drugs Market
The global Anticancer Drugs market was valued at US$ 84270 million in 2019 and will reach US$ 108880 million by the end of 2026, growing at a CAGR of 3.7% during 2020-2026.
Global Anticancer Drugs Scope and Market Size
The global Anticancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anticancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anticancer Drugs market is segmented into
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
Segment by Application, the Anticancer Drugs market is segmented into
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
The Anticancer Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Anticancer Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anticancer Drugs Market Share Analysis
Anticancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anticancer Drugs business, the date to enter into the Anticancer Drugs market, Anticancer Drugs product introduction, recent developments, etc.
The major vendors covered:
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
CELGENE CORPORATION
Novartis AG
Pfizer Inc
Amgen Inc
Bayer AG
AstraZeneca
Takeda Pharmaceutical Company Limited
Merck & Co.
Table of Contents
1 Anticancer Drugs Market Overview
1.1 Anticancer Drugs Product Scope
1.2 Anticancer Drugs Segment by Type
1.2.1 Global Anticancer Drugs Sales by Type (2020-2026)
1.2.2 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
1.2.3 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
1.2.4 Hormonal Drugs
1.3 Anticancer Drugs Segment by Application
1.3.1 Global Anticancer Drugs Sales Comparison by Application (2020-2026)
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Leukemia
1.3.5 Colorectal Cancer
1.4 Anticancer Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anticancer Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Anticancer Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Anticancer Drugs Price Trends (2015-2026)
2 Anticancer Drugs Estimate and Forecast by Region
2.1 Global Anticancer Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anticancer Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anticancer Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Anticancer Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Anticancer Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anticancer Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anticancer Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anticancer Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Anticancer Drugs Estimates and Projections (2015-2026)
2.4.3 China Anticancer Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Anticancer Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anticancer Drugs Estimates and Projections (2015-2026)
2.4.6 India Anticancer Drugs Estimates and Projections (2015-2026)
3 Global Anticancer Drugs Competition Landscape by Players
3.1 Global Top Anticancer Drugs Players by Sales (2015-2020)
3.2 Global Top Anticancer Drugs Players by Revenue (2015-2020)
3.3 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticancer Drugs as of 2019)
3.4 Global Anticancer Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Anticancer Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anticancer Drugs Players (Opinion Leaders)
4 Global Anticancer Drugs Market Size by Type
4.1 Global Anticancer Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Anticancer Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Anticancer Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Anticancer Drugs Price by Type (2014-2020)
4.2 Global Anticancer Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anticancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anticancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Anticancer Drugs Price Forecast by Type (2021-2026)
5 Global Anticancer Drugs Market Size by Application
5.1 Global Anticancer Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Anticancer Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Anticancer Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Anticancer Drugs Price by Application (2015-2020)
5.2 Global Anticancer Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anticancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anticancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anticancer Drugs Price Forecast by Application (2021-2026)
3 North America Anticancer Drugs Market Facts & Figures
3.2 North America Anticancer Drugs Sales Market Share by Company (2015-2020)
3.3 North America Anticancer Drugs Sales Market Share by Type (2015-2020)
3.4 North America Anticancer Drugs Sales Market Share by Application (2015-2020)
4 Europe Anticancer Drugs Market Facts & Figures
4.2 Europe Anticancer Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Anticancer Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Anticancer Drugs Sales Market Share by Application (2015-2020)
5 China Anticancer Drugs Market Facts & Figures
5.2 China Anticancer Drugs Sales Market Share by Company (2015-2020)
5.3 China Anticancer Drugs Sales Market Share by Type (2015-2020)
5.4 China Anticancer Drugs Sales Market Share by Application (2015-2020)
6 Japan Anticancer Drugs Market Facts & Figures
6.2 Japan Anticancer Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Anticancer Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Anticancer Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Anticancer Drugs Market Facts & Figures
7.2 Southeast Asia Anticancer Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Anticancer Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Anticancer Drugs Sales Market Share by Application (2015-2020)
8 India Anticancer Drugs Market Facts & Figures
8.2 India Anticancer Drugs Sales Market Share by Company (2015-2020)
8.3 India Anticancer Drugs Sales Market Share by Type (2015-2020)
8.4 India Anticancer Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Anticancer Drugs Business
12.1 F. Hoffmann-La Roche Ltd
12.1.1 F. Hoffmann-La Roche Ltd Anticancer Drugs Corporation Information
12.1.2 F. Hoffmann-La Roche Ltd Anticancer Drugs Business Overview and Total Revenue
12.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered
12.1.5 F. Hoffmann-La Roche Ltd Recent Development
12.2 Eli Lilly and Company
12.2.1 Eli Lilly and Company Anticancer Drugs Corporation Information
12.2.2 Eli Lilly and Company Anticancer Drugs Business Overview and Total Revenue
12.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eli Lilly and Company Anticancer Drugs Products Offered
12.2.5 Eli Lilly and Company Recent Development
12.3 CELGENE CORPORATION
12.3.1 CELGENE CORPORATION Anticancer Drugs Corporation Information
12.3.2 CELGENE CORPORATION Anticancer Drugs Business Overview and Total Revenue
12.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CELGENE CORPORATION Anticancer Drugs Products Offered
12.3.5 CELGENE CORPORATION Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Anticancer Drugs Corporation Information
12.4.2 Novartis AG Anticancer Drugs Business Overview and Total Revenue
12.4.3 Novartis AG Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis AG Anticancer Drugs Products Offered
12.4.5 Novartis AG Recent Development
12.5 Pfizer Inc
12.5.1 Pfizer Inc Anticancer Drugs Corporation Information
12.5.2 Pfizer Inc Anticancer Drugs Business Overview and Total Revenue
12.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Inc Anticancer Drugs Products Offered
12.5.5 Pfizer Inc Recent Development
12.6 Amgen Inc
12.6.1 Amgen Inc Anticancer Drugs Corporation Information
12.6.2 Amgen Inc Anticancer Drugs Business Overview and Total Revenue
12.6.3 Amgen Inc Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Amgen Inc Anticancer Drugs Products Offered
12.6.5 Amgen Inc Recent Development
12.7 Bayer AG
12.7.1 Bayer AG Anticancer Drugs Corporation Information
12.7.2 Bayer AG Anticancer Drugs Business Overview and Total Revenue
12.7.3 Bayer AG Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bayer AG Anticancer Drugs Products Offered
12.7.5 Bayer AG Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Anticancer Drugs Corporation Information
12.8.2 AstraZeneca Anticancer Drugs Business Overview and Total Revenue
12.8.3 AstraZeneca Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AstraZeneca Anticancer Drugs Products Offered
12.8.5 AstraZeneca Recent Development
12.9 Takeda Pharmaceutical Company Limited
12.9.1 Takeda Pharmaceutical Company Limited Anticancer Drugs Corporation Information
12.9.2 Takeda Pharmaceutical Company Limited Anticancer Drugs Business Overview and Total Revenue
12.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Takeda Pharmaceutical Company Limited Anticancer Drugs Products Offered
12.9.5 Takeda Pharmaceutical Company Limited Recent Development
12.10 Merck & Co.
12.10.1 Merck & Co. Anticancer Drugs Corporation Information
12.10.2 Merck & Co. Anticancer Drugs Business Overview and Total Revenue
12.10.3 Merck & Co. Anticancer Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merck & Co. Anticancer Drugs Products Offered
12.10.5 Merck & Co. Recent Development
13 Anticancer Drugs Manufacturing Cost Analysis
13.1 Anticancer Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anticancer Drugs
13.4 Anticancer Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anticancer Drugs Distributors List
14.3 Anticancer Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anticancer Drugs Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Anticancer Drugs Sales (MT) Comparison by Application (2020-2026)
Table 3. Global Market Anticancer Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Anticancer Drugs Sales (MT) by Region (2015-2020)
Table 5. Global Anticancer Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Anticancer Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Anticancer Drugs Revenue Share by Region (2015-2020)
Table 8. Global Anticancer Drugs Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Anticancer Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Anticancer Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Anticancer Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Anticancer Drugs (MT) of Key Companies (2015-2020)
Table 13. Global Anticancer Drugs Sales Share by Company (2015-2020)
Table 14. Global Anticancer Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Anticancer Drugs Revenue Share by Company (2015-2020)
Table 16. Global Anticancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticancer Drugs as of 2019)
Table 17. Global Anticancer Drugs Average Price (USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Anticancer Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Anticancer Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Anticancer Drugs Players
Table 22. Global Anticancer Drugs Sales (MT) by Type (2015-2020)
Table 23. Global Anticancer Drugs Sales Share by Type (2015-2020)
Table 24. Global Anticancer Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Anticancer Drugs Price (MT) by Type (2015-2020)
Table 26. Global Anticancer Drugs Sales Share by Type (2021-2026)
Table 27. Global Anticancer Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Anticancer Drugs Revenue Share by Type (2021-2026)
Table 29. Global Anticancer Drugs Price (MT) by Type (2021-2026)
Table 30. Global Anticancer Drugs Sales (MT) by Application (2015-2020)
Table 31. Global Anticancer Drugs Sales Share by Application (2015-2020)
Table 32. Global Anticancer Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Anticancer Drugs Price (MT) by Application (2015-2020)
Table 34. Global Anticancer Drugs Sales (MT) by Application (2021-2026)
Table 35. Global Anticancer Drugs Sales Share by Application (2021-2026)
Table 36. Global Anticancer Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Anticancer Drugs Revenue Share by Application (2021-2026)
Table 38. Global Anticancer Drugs Price (MT) by Application (2021-2026)
Table 39. United States Anticancer Drugs Sales (MT) by Company (2015-2020)
Table 40. United States Anticancer Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Anticancer Drugs Sales (MT) by Type (2015-2020)
Table 42. United States Anticancer Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Anticancer Drugs Sales (MT) by Application (2015-2020)
Table 44. United States Anticancer Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Anticancer Drugs Sales (MT) by Company (2015-2020)
Table 46. Europe Anticancer Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Anticancer Drugs Sales (MT) by Type (2015-2020)
Table 48. Europe Anticancer Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Anticancer Drugs Sales (MT) by Application (2015-2020)
Table 50. Europe Anticancer Drugs Sales Market Share by Type (2015-2020)
Table 51. China Anticancer Drugs Sales (MT) by Company (2015-2020)
Table 52. China Anticancer Drugs Sales Market Share by Company (2015-2020)
Table 53. China Anticancer Drugs Sales (MT) by Type (2015-2020)
Table 54. China Anticancer Drugs Sales Market Share by Type (2015-2020)
Table 55. China Anticancer Drugs Sales (MT) by Application (2015-2020)
Table 56. China Anticancer Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Anticancer Drugs Sales (MT) by Company (2015-2020)
Table 58. Japan Anticancer Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Anticancer Drugs Sales (MT) by Type (2015-2020)
Table 60. Japan Anticancer Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Anticancer Drugs Sales (MT) by Application (2015-2020)
Table 62. Japan Anticancer Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Anticancer Drugs Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Anticancer Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Anticancer Drugs Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Anticancer Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Anticancer Drugs Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Anticancer Drugs Sales Market Share by Application (2015-2020)
Table 69. India Anticancer Drugs Sales (MT) by Company (2015-2020)
Table 70. India Anticancer Drugs Sales Market Share by Company (2015-2020)
Table 71. India Anticancer Drugs Sales (MT) by Type (2015-2020)
Table 72. India Anticancer Drugs Sales Market Share by Type (2015-2020)
Table 73. India Anticancer Drugs Sales (MT) by Application (2015-2020)
Table 74. India Anticancer Drugs Sales Market Share by Application (2015-2020)
Table 75. F. Hoffmann-La Roche Ltd Corporation Information
Table 76. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 77. F. Hoffmann-La Roche Ltd Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. F. Hoffmann-La Roche Ltd Anticancer Drugs Product
Table 79. F. Hoffmann-La Roche Ltd Recent Development
Table 80. Eli Lilly and Company Corporation Information
Table 81. Eli Lilly and Company Description and Business Overview
Table 82. Eli Lilly and Company Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Eli Lilly and Company Anticancer Drugs Product
Table 84. Eli Lilly and Company Recent Development
Table 85. CELGENE CORPORATION Corporation Information
Table 86. CELGENE CORPORATION Description and Business Overview
Table 87. CELGENE CORPORATION Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. CELGENE CORPORATION Anticancer Drugs Product
Table 89. CELGENE CORPORATION Recent Development
Table 90. Novartis AG Corporation Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Novartis AG Anticancer Drugs Product
Table 94. Novartis AG Recent Development
Table 95. Pfizer Inc Corporation Information
Table 96. Pfizer Inc Description and Business Overview
Table 97. Pfizer Inc Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Pfizer Inc Anticancer Drugs Product
Table 99. Pfizer Inc Recent Development
Table 100. Amgen Inc Corporation Information
Table 101. Amgen Inc Description and Business Overview
Table 102. Amgen Inc Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Amgen Inc Anticancer Drugs Product
Table 104. Amgen Inc Recent Development
Table 105. Bayer AG Corporation Information
Table 106. Bayer AG Description and Business Overview
Table 107. Bayer AG Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Bayer AG Anticancer Drugs Product
Table 109. Bayer AG Recent Development
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. AstraZeneca Description and Business Overview
Table 113. AstraZeneca Anticancer Drugs Product
Table 114. AstraZeneca Recent Development
Table 115. Takeda Pharmaceutical Company Limited Corporation Information
Table 116. Takeda Pharmaceutical Company Limited Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 118. Takeda Pharmaceutical Company Limited Anticancer Drugs Product
Table 119. Takeda Pharmaceutical Company Limited Recent Development
Table 120. Merck & Co. Corporation Information
Table 121. Merck & Co. Description and Business Overview
Table 122. Merck & Co. Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 123. Merck & Co. Anticancer Drugs Product
Table 124. Merck & Co. Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Anticancer Drugs Distributors List
Table 128. Anticancer Drugs Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticancer Drugs Product Picture
Figure 2. Global Anticancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anticancer Drugs Market Share by Application in 2020 & 2026
Figure 6. Lung Cancer Examples
Figure 7. Breast Cancer Examples
Figure 8. Leukemia Examples
Figure 9. Colorectal Cancer Examples
Figure 10. Global Anticancer Drugs Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Anticancer Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Anticancer Drugs Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 13. Global Anticancer Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Anticancer Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Anticancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Anticancer Drugs Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Anticancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Anticancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Anticancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Anticancer Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Anticancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Anticancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Anticancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Anticancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Anticancer Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Anticancer Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Anticancer Drugs Players Market Share by Revenue in Anticancer Drugs 2015 & 2019
Figure 28. Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Anticancer Drugs Revenue Share by Type (2015-2020)
Figure 30. Global Anticancer Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Anticancer Drugs Revenue Share by Application (2015-2020)
Figure 32. Global Anticancer Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Anticancer Drugs Sales Market Share by Type in 2019
Figure 34. United States Anticancer Drugs Sales Market Share by Type in 2019
Figure 35. Europe Anticancer Drugs Sales Market Share by Company in 2019
Figure 36. Europe Anticancer Drugs Sales Market Share by Type in 2019
Figure 37. Europe Anticancer Drugs Sales Market Share by Application in 2019
Figure 38. China Anticancer Drugs Sales Market Share by Company in 2019
Figure 39. China Anticancer Drugs Sales Market Share by Type in 2019
Figure 40. China Anticancer Drugs Sales Market Share by Application in 2019
Figure 41. Japan Anticancer Drugs Sales Market Share by Company in 2019
Figure 42. Japan Anticancer Drugs Sales Market Share by Type in 2019
Figure 43. Japan Anticancer Drugs Sales Market Share by Application in 2019
Figure 44. Southeast Asia Anticancer Drugs Sales Market Share by Company in 2019
Figure 45. Southeast Asia Anticancer Drugs Sales Market Share by Type in 2019
Figure 46. Southeast Asia Anticancer Drugs Sales Market Share by Application in 2019
Figure 47. India Anticancer Drugs Sales Market Share by Company in 2019
Figure 48. India Anticancer Drugs Sales Market Share by Type in 2019
Figure 49. India Anticancer Drugs Sales Market Share by Application in 2019
Figure 50. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CELGENE CORPORATION Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Pfizer Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Takeda Pharmaceutical Company Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Anticancer Drugs
Figure 62. Manufacturing Process Analysis of Anticancer Drugs
Figure 63. Anticancer Drugs Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…- 泌尿生殖器薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Genitourinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genitourinary Drugs marke…
- 癌用治療薬の世界市場レポート2020 Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targ…
- 尿路上皮がん治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Urothelial Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1565.9 million by 2025, from USD 980.1 million in 2019. The Urothelial C…
- 頭頸部がん治療薬/治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Head and Neck Cancer Drugs/Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1466.9 million by 2025, from USD 1255.8 million in 2019. …